GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » DeferredTaxAndRevenue

Prism Biolab Co (TSE:206A) DeferredTaxAndRevenue : 円0.0 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Prism Biolab Co's current deferred tax and revenue for the quarter that ended in Mar. 2025 was 円0.0 Mil.

Prism Biolab Co DeferredTaxAndRevenue Historical Data

The historical data trend for Prism Biolab Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co DeferredTaxAndRevenue Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24
DeferredTaxAndRevenue
- - -

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24 Mar25
DeferredTaxAndRevenue - - - - -

Prism Biolab Co DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Prism Biolab Co Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines